

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.80104633 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.60312146 |
| 3 | muscle filament sliding (GO:0030049) | 9.60312146 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.87894674 |
| 5 | myofibril assembly (GO:0030239) | 8.24516459 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.20202432 |
| 7 | actin-mediated cell contraction (GO:0070252) | 8.01751304 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.32925671 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.95635790 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.91746849 |
| 11 | plasma membrane repair (GO:0001778) | 6.75436287 |
| 12 | cardiac muscle cell development (GO:0055013) | 6.64456720 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.50804357 |
| 14 | actomyosin structure organization (GO:0031032) | 6.44619061 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.28161599 |
| 16 | cardiac cell development (GO:0055006) | 6.24363918 |
| 17 | striated muscle contraction (GO:0006941) | 6.20921084 |
| 18 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.18115348 |
| 19 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.08989537 |
| 20 | adult heart development (GO:0007512) | 6.04330137 |
| 21 | actin filament-based movement (GO:0030048) | 6.03967653 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 5.90680230 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 5.75462821 |
| 24 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.72287182 |
| 25 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.68501780 |
| 26 | regulation of sarcomere organization (GO:0060297) | 5.66473676 |
| 27 | striated muscle hypertrophy (GO:0014897) | 5.62935673 |
| 28 | muscle tissue morphogenesis (GO:0060415) | 5.61548144 |
| 29 | regulation of relaxation of muscle (GO:1901077) | 5.59652160 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.51270434 |
| 31 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.45157429 |
| 32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.34714614 |
| 33 | heart process (GO:0003015) | 5.19737883 |
| 34 | heart contraction (GO:0060047) | 5.19737883 |
| 35 | skeletal muscle contraction (GO:0003009) | 5.18845553 |
| 36 | tricarboxylic acid cycle (GO:0006099) | 5.16321691 |
| 37 | regulation of striated muscle contraction (GO:0006942) | 5.13535582 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.09375120 |
| 39 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.05775907 |
| 40 | creatine metabolic process (GO:0006600) | 5.01365191 |
| 41 | muscle hypertrophy (GO:0014896) | 4.99070398 |
| 42 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.97415316 |
| 43 | heart trabecula formation (GO:0060347) | 4.91127829 |
| 44 | regulation of cell communication by electrical coupling (GO:0010649) | 4.85514991 |
| 45 | regulation of the force of heart contraction (GO:0002026) | 4.74089660 |
| 46 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.66664796 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.64939042 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.62833629 |
| 49 | carnitine shuttle (GO:0006853) | 4.58122276 |
| 50 | regulation of cardioblast differentiation (GO:0051890) | 4.42830816 |
| 51 | response to inactivity (GO:0014854) | 4.42726533 |
| 52 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.38604658 |
| 53 | muscle hypertrophy in response to stress (GO:0003299) | 4.37220319 |
| 54 | cardiac muscle adaptation (GO:0014887) | 4.37220319 |
| 55 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.37220319 |
| 56 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.35595735 |
| 57 | negative regulation of protein localization to cell surface (GO:2000009) | 4.33281654 |
| 58 | striated muscle cell development (GO:0055002) | 4.32950027 |
| 59 | cell communication involved in cardiac conduction (GO:0086065) | 4.30014275 |
| 60 | muscle contraction (GO:0006936) | 4.16729064 |
| 61 | skeletal muscle fiber development (GO:0048741) | 4.16361047 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.12775082 |
| 63 | striated muscle adaptation (GO:0014888) | 4.03694977 |
| 64 | cell communication by electrical coupling (GO:0010644) | 4.01112003 |
| 65 | myotube cell development (GO:0014904) | 3.98610688 |
| 66 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.94339158 |
| 67 | cardiac muscle cell action potential (GO:0086001) | 3.93926215 |
| 68 | regulation of cardiac muscle contraction (GO:0055117) | 3.93448924 |
| 69 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.92544877 |
| 70 | negative regulation of potassium ion transport (GO:0043267) | 3.92295163 |
| 71 | cardiac ventricle formation (GO:0003211) | 3.92116185 |
| 72 | muscle system process (GO:0003012) | 3.88996683 |
| 73 | regulation of heart rate (GO:0002027) | 3.87100309 |
| 74 | regulation of ATP catabolic process (GO:1903289) | 3.85667687 |
| 75 | regulation of ATPase activity (GO:0043462) | 3.85667687 |
| 76 | fatty acid transmembrane transport (GO:1902001) | 3.82760786 |
| 77 | NADH metabolic process (GO:0006734) | 3.80470932 |
| 78 | cardiac chamber formation (GO:0003207) | 3.76445679 |
| 79 | muscle cell development (GO:0055001) | 3.75464675 |
| 80 | skeletal muscle adaptation (GO:0043501) | 3.74174928 |
| 81 | muscle fiber development (GO:0048747) | 3.71559234 |
| 82 | ventricular cardiac muscle cell development (GO:0055015) | 3.69616908 |
| 83 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.64089516 |
| 84 | skeletal muscle tissue development (GO:0007519) | 3.63337978 |
| 85 | regulation of coenzyme metabolic process (GO:0051196) | 3.62280736 |
| 86 | regulation of cofactor metabolic process (GO:0051193) | 3.62280736 |
| 87 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.59636572 |
| 88 | regulation of heart contraction (GO:0008016) | 3.58717130 |
| 89 | positive regulation of myotube differentiation (GO:0010831) | 3.58621477 |
| 90 | regulation of muscle contraction (GO:0006937) | 3.57765184 |
| 91 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.53355743 |
| 92 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.53355743 |
| 93 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.51445171 |
| 94 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.50463173 |
| 95 | striated muscle atrophy (GO:0014891) | 3.43652634 |
| 96 | muscle adaptation (GO:0043500) | 3.40834940 |
| 97 | response to caffeine (GO:0031000) | 3.39276855 |
| 98 | positive regulation of cation channel activity (GO:2001259) | 3.39195875 |
| 99 | ATP synthesis coupled proton transport (GO:0015986) | 3.37315320 |
| 100 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.37315320 |
| 101 | atrial septum morphogenesis (GO:0060413) | 3.36684833 |
| 102 | cardiac conduction (GO:0061337) | 3.36550116 |
| 103 | muscle organ development (GO:0007517) | 3.34784538 |
| 104 | muscle structure development (GO:0061061) | 3.33327521 |
| 105 | relaxation of muscle (GO:0090075) | 3.32822736 |
| 106 | muscle cell cellular homeostasis (GO:0046716) | 3.31045292 |
| 107 | relaxation of cardiac muscle (GO:0055119) | 3.30960333 |
| 108 | regulation of muscle system process (GO:0090257) | 3.30365101 |
| 109 | muscle cell fate commitment (GO:0042693) | 3.28413030 |
| 110 | carnitine transmembrane transport (GO:1902603) | 3.27665109 |
| 111 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.27219516 |
| 112 | trabecula formation (GO:0060343) | 3.26880911 |
| 113 | glycogen biosynthetic process (GO:0005978) | 3.25990488 |
| 114 | glucan biosynthetic process (GO:0009250) | 3.25990488 |
| 115 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.24868530 |
| 116 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.23846502 |
| 117 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.23846502 |
| 118 | response to muscle activity (GO:0014850) | 3.22686618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.60210314 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.09316926 |
| 3 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.35910744 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.35910744 |
| 5 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.96115816 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.87399017 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.86523436 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.81877304 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.78253130 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.21174578 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.95642248 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.79014788 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.78136083 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71712953 |
| 15 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.60281111 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.39639045 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37146145 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32126032 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.30629079 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.14776922 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98254212 |
| 22 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.98126331 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.94881909 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77828752 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75782592 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71864689 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71558732 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70029682 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62414551 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61658472 |
| 31 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.61326237 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54035249 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47437932 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43335597 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39857135 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.39725188 |
| 37 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.38784954 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38769906 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37211235 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37038815 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35562112 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34699378 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31875712 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30997230 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.29618256 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26582175 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26486238 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24803320 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22462650 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22436680 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20202315 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18239930 |
| 53 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.17824306 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17664907 |
| 55 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17425795 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16292399 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16023683 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15558103 |
| 59 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14221571 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14133192 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12556552 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10829769 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09474614 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09184242 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08613336 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07361897 |
| 67 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07008581 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06839713 |
| 69 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06396804 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06224337 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06209420 |
| 72 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05948920 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04023839 |
| 74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03531532 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03016859 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02311920 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01815414 |
| 78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01812078 |
| 79 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.00888661 |
| 80 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00188807 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99190158 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99110727 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98869255 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98657149 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97800300 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97051578 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96529595 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95550501 |
| 89 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95427592 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.94602571 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94388131 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94088803 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93402838 |
| 94 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93364824 |
| 95 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93048493 |
| 96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92639189 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92609036 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92419901 |
| 99 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91632181 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91308143 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91156018 |
| 102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91136180 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90625629 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90454705 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90140336 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90092214 |
| 107 | TBL1_22424771_ChIP-Seq_293T_Human | 0.90017400 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89662178 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89408101 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89139442 |
| 111 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89139442 |
| 112 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88761260 |
| 113 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.88696694 |
| 114 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.88696694 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87954307 |
| 116 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86512667 |
| 117 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86070873 |
| 118 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.85834305 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85444984 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85352055 |
| 121 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85143265 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84988479 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84745583 |
| 124 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84228272 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84139516 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84056553 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83930067 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83930067 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83891896 |
| 130 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83419306 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83001703 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82760345 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82292349 |
| 134 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82065506 |
| 135 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81968574 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80070942 |
| 137 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79359847 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77967764 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77298304 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76271743 |
| 141 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75371097 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75294731 |
| 143 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74317434 |
| 144 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.73778100 |
| 145 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73515281 |
| 146 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72965089 |
| 147 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.72199863 |
| 148 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.71979140 |
| 149 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.71849212 |
| 150 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.71750793 |
| 151 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.71014857 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70306936 |
| 153 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.67552493 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67497283 |
| 155 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66448003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.28667339 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.81698343 |
| 3 | MP0000751_myopathy | 5.33466077 |
| 4 | MP0003646_muscle_fatigue | 4.76103659 |
| 5 | MP0000749_muscle_degeneration | 4.71067880 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.46094773 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.42910586 |
| 8 | MP0005330_cardiomyopathy | 3.91522045 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.38095072 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.37161774 |
| 11 | MP0002972_abnormal_cardiac_muscle | 3.20157421 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.11197357 |
| 13 | MP0002106_abnormal_muscle_physiology | 2.98637699 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.94062126 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.89272874 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.80307235 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.67221767 |
| 18 | MP0005385_cardiovascular_system_phenoty | 2.50081890 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 2.50081890 |
| 20 | MP0002269_muscular_atrophy | 2.49122376 |
| 21 | MP0000747_muscle_weakness | 2.44485366 |
| 22 | MP0005369_muscle_phenotype | 2.42958107 |
| 23 | MP0003828_pulmonary_edema | 2.36777167 |
| 24 | MP0006138_congestive_heart_failure | 2.33844682 |
| 25 | MP0000759_abnormal_skeletal_muscle | 2.33600496 |
| 26 | MP0004484_altered_response_of | 2.16755193 |
| 27 | MP0004130_abnormal_muscle_cell | 2.04085493 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.04077955 |
| 29 | MP0004085_abnormal_heartbeat | 2.03151305 |
| 30 | MP0004510_myositis | 1.91991986 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.91811337 |
| 32 | MP0004233_abnormal_muscle_weight | 1.88935849 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.83516422 |
| 34 | MP0003567_abnormal_fetal_cardiomyocyte | 1.57282027 |
| 35 | MP0000733_abnormal_muscle_development | 1.41511817 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.37293492 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.28257974 |
| 38 | MP0003279_aneurysm | 1.19085224 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.18547294 |
| 40 | MP0000266_abnormal_heart_morphology | 1.17812738 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.12527702 |
| 42 | MP0005451_abnormal_body_composition | 1.03764535 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.01251128 |
| 44 | MP0010368_abnormal_lymphatic_system | 0.99393657 |
| 45 | MP0005623_abnormal_meninges_morphology | 0.99385683 |
| 46 | MP0004270_analgesia | 0.94327827 |
| 47 | MP0001661_extended_life_span | 0.93804483 |
| 48 | MP0005670_abnormal_white_adipose | 0.92178839 |
| 49 | MP0003566_abnormal_cell_adhesion | 0.90858892 |
| 50 | MP0000343_altered_response_to | 0.86650524 |
| 51 | MP0004272_abnormal_basement_membrane | 0.85201212 |
| 52 | MP0002128_abnormal_blood_circulation | 0.82947598 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 0.80029017 |
| 54 | MP0000767_abnormal_smooth_muscle | 0.77918061 |
| 55 | MP0005165_increased_susceptibility_to | 0.75629229 |
| 56 | MP0005375_adipose_tissue_phenotype | 0.69661946 |
| 57 | MP0005266_abnormal_metabolism | 0.68463457 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 0.67802105 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.65586004 |
| 60 | MP0002638_abnormal_pupillary_reflex | 0.64961523 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.60823908 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 0.60629050 |
| 63 | MP0000230_abnormal_systemic_arterial | 0.59690892 |
| 64 | MP0002971_abnormal_brown_adipose | 0.59601249 |
| 65 | MP0003941_abnormal_skin_development | 0.58106861 |
| 66 | MP0002925_abnormal_cardiovascular_devel | 0.57565890 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.57202683 |
| 68 | MP0003122_maternal_imprinting | 0.55613539 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.52311037 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.49748282 |
| 71 | MP0001784_abnormal_fluid_regulation | 0.48472829 |
| 72 | MP0005275_abnormal_skin_tensile | 0.48148528 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 0.46377755 |
| 74 | MP0003984_embryonic_growth_retardation | 0.46308088 |
| 75 | MP0005503_abnormal_tendon_morphology | 0.45883545 |
| 76 | MP0002822_catalepsy | 0.45160860 |
| 77 | MP0001614_abnormal_blood_vessel | 0.42863262 |
| 78 | MP0000003_abnormal_adipose_tissue | 0.41729854 |
| 79 | MP0003136_yellow_coat_color | 0.41346987 |
| 80 | MP0003948_abnormal_gas_homeostasis | 0.40325966 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.40133930 |
| 82 | MP0003878_abnormal_ear_physiology | 0.40133930 |
| 83 | MP0004142_abnormal_muscle_tone | 0.36657922 |
| 84 | MP0003385_abnormal_body_wall | 0.35270647 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.33522545 |
| 86 | MP0001984_abnormal_olfaction | 0.33417007 |
| 87 | MP0004924_abnormal_behavior | 0.33141228 |
| 88 | MP0005386_behavior/neurological_phenoty | 0.33141228 |
| 89 | MP0003879_abnormal_hair_cell | 0.31906250 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.30986603 |
| 91 | MP0008569_lethality_at_weaning | 0.30958921 |
| 92 | MP0001529_abnormal_vocalization | 0.29301231 |
| 93 | MP0005187_abnormal_penis_morphology | 0.28980728 |
| 94 | MP0009250_abnormal_appendicular_skeleto | 0.28876700 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.28249654 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.27787935 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 0.27114274 |
| 98 | MP0005380_embryogenesis_phenotype | 0.27114274 |
| 99 | MP0005332_abnormal_amino_acid | 0.25470162 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.25361736 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.25257801 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.25048871 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 0.24856193 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.24835609 |
| 105 | MP0002734_abnormal_mechanical_nocicepti | 0.24270102 |
| 106 | MP0002249_abnormal_larynx_morphology | 0.23933829 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.23214562 |
| 108 | MP0000762_abnormal_tongue_morphology | 0.22919712 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.22853450 |
| 110 | MP0004043_abnormal_pH_regulation | 0.22341388 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.21958220 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.21872344 |
| 113 | MP0002272_abnormal_nervous_system | 0.21813594 |
| 114 | MP0004147_increased_porphyrin_level | 0.21780714 |
| 115 | MP0009672_abnormal_birth_weight | 0.21605180 |
| 116 | MP0005388_respiratory_system_phenotype | 0.20275054 |
| 117 | MP0002133_abnormal_respiratory_system | 0.20275054 |
| 118 | MP0005535_abnormal_body_temperature | 0.19928114 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.19745272 |
| 120 | MP0002102_abnormal_ear_morphology | 0.19670839 |
| 121 | MP0003045_fibrosis | 0.19232493 |
| 122 | MP0001175_abnormal_lung_morphology | 0.18948051 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.18543768 |
| 124 | MP0004134_abnormal_chest_morphology | 0.18191196 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.18105793 |
| 126 | MP0004197_abnormal_fetal_growth/weight/ | 0.17921439 |
| 127 | MP0002114_abnormal_axial_skeleton | 0.17836314 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.17820259 |
| 129 | MP0001727_abnormal_embryo_implantation | 0.17621744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.92055853 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.56093832 |
| 3 | Muscle fiber splitting (HP:0003555) | 6.24780212 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.17212159 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.16475338 |
| 6 | Exercise-induced myalgia (HP:0003738) | 6.15253690 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.99542009 |
| 8 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.84720061 |
| 9 | Subaortic stenosis (HP:0001682) | 5.84720061 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.84154674 |
| 11 | Atrial fibrillation (HP:0005110) | 5.36571449 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 5.34647852 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 5.29995474 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.15724339 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 5.12851493 |
| 16 | Lipoatrophy (HP:0100578) | 5.02570164 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 5.01242482 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.93634874 |
| 19 | Supraventricular tachycardia (HP:0004755) | 4.84152351 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 4.75762645 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 4.59706395 |
| 22 | Nemaline bodies (HP:0003798) | 4.44438386 |
| 23 | Syncope (HP:0001279) | 4.26486193 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 4.15869433 |
| 25 | Myoglobinuria (HP:0002913) | 4.15354938 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 4.05491197 |
| 27 | Increased connective tissue (HP:0009025) | 4.01982765 |
| 28 | Prolonged QT interval (HP:0001657) | 4.00994176 |
| 29 | Difficulty running (HP:0009046) | 3.96167732 |
| 30 | Ventricular arrhythmia (HP:0004308) | 3.89115447 |
| 31 | Palpitations (HP:0001962) | 3.66645458 |
| 32 | Bundle branch block (HP:0011710) | 3.61304914 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.42817437 |
| 34 | Myotonia (HP:0002486) | 3.42765102 |
| 35 | Distal arthrogryposis (HP:0005684) | 3.33674808 |
| 36 | Neck muscle weakness (HP:0000467) | 3.29914101 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.29873647 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.23926394 |
| 39 | Round ear (HP:0100830) | 3.21332771 |
| 40 | Heart block (HP:0012722) | 3.18212506 |
| 41 | Atrioventricular block (HP:0001678) | 3.13803834 |
| 42 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.08500312 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 3.02727995 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.99502626 |
| 45 | Abnormal EKG (HP:0003115) | 2.88922796 |
| 46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.87631934 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 2.79928546 |
| 48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.76665853 |
| 49 | Generalized muscle weakness (HP:0003324) | 2.74302649 |
| 50 | Left ventricular hypertrophy (HP:0001712) | 2.67743941 |
| 51 | Myopathic facies (HP:0002058) | 2.63455515 |
| 52 | Gowers sign (HP:0003391) | 2.61696510 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.60711301 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.59569524 |
| 55 | Muscle stiffness (HP:0003552) | 2.57561524 |
| 56 | Areflexia of lower limbs (HP:0002522) | 2.54803574 |
| 57 | Ulnar deviation of the wrist (HP:0003049) | 2.46856368 |
| 58 | Palmoplantar keratoderma (HP:0000982) | 2.41599288 |
| 59 | Hip contracture (HP:0003273) | 2.40428822 |
| 60 | Malignant hyperthermia (HP:0002047) | 2.39586840 |
| 61 | Scapular winging (HP:0003691) | 2.39518803 |
| 62 | Hypoplastic heart (HP:0001961) | 2.39356363 |
| 63 | Rimmed vacuoles (HP:0003805) | 2.35607608 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.32781206 |
| 65 | Abnormality of the neuromuscular junction (HP:0003398) | 2.32583510 |
| 66 | Fatigable weakness (HP:0003473) | 2.32583510 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.29147850 |
| 68 | Weak cry (HP:0001612) | 2.26245141 |
| 69 | Limb-girdle muscle atrophy (HP:0003797) | 2.21125929 |
| 70 | Hypoplastic ischia (HP:0003175) | 2.20511936 |
| 71 | Abnormality of the foot musculature (HP:0001436) | 2.15859572 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.12004121 |
| 73 | Muscular dystrophy (HP:0003560) | 2.11328049 |
| 74 | Bulbar palsy (HP:0001283) | 2.10006006 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.07095095 |
| 76 | Congenital malformation of the right heart (HP:0011723) | 2.05121058 |
| 77 | Double outlet right ventricle (HP:0001719) | 2.05121058 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.04520953 |
| 79 | Testicular atrophy (HP:0000029) | 2.03372867 |
| 80 | Calcaneovalgus deformity (HP:0001848) | 1.95545129 |
| 81 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93539300 |
| 82 | Facial diplegia (HP:0001349) | 1.93531588 |
| 83 | Sudden cardiac death (HP:0001645) | 1.93497983 |
| 84 | Spinal rigidity (HP:0003306) | 1.92527380 |
| 85 | Hepatic necrosis (HP:0002605) | 1.91255922 |
| 86 | Waddling gait (HP:0002515) | 1.90130203 |
| 87 | Hyperkalemia (HP:0002153) | 1.89461181 |
| 88 | Abnormality of the ischium (HP:0003174) | 1.89309840 |
| 89 | Frequent falls (HP:0002359) | 1.88997495 |
| 90 | Aplasia of the musculature (HP:0100854) | 1.88822017 |
| 91 | Popliteal pterygium (HP:0009756) | 1.88415700 |
| 92 | Abnormality of the calcaneus (HP:0008364) | 1.87813861 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.85207240 |
| 94 | Absent phalangeal crease (HP:0006109) | 1.84865246 |
| 95 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83428629 |
| 96 | Hypoplastic left heart (HP:0004383) | 1.83142232 |
| 97 | Progressive muscle weakness (HP:0003323) | 1.83058764 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82976994 |
| 99 | Congestive heart failure (HP:0001635) | 1.82501399 |
| 100 | Conjunctival hamartoma (HP:0100780) | 1.80585583 |
| 101 | Proximal amyotrophy (HP:0007126) | 1.80004233 |
| 102 | Easy fatigability (HP:0003388) | 1.79093302 |
| 103 | Exercise intolerance (HP:0003546) | 1.76868454 |
| 104 | Lower limb amyotrophy (HP:0007210) | 1.76219016 |
| 105 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.74858370 |
| 106 | Deformed tarsal bones (HP:0008119) | 1.73642516 |
| 107 | Steppage gait (HP:0003376) | 1.72808801 |
| 108 | Muscle fiber atrophy (HP:0100295) | 1.70597144 |
| 109 | Limited hip movement (HP:0008800) | 1.68946192 |
| 110 | Increased intramyocellular lipid droplets (HP:0012240) | 1.61137217 |
| 111 | Slender build (HP:0001533) | 1.53720674 |
| 112 | Metatarsus adductus (HP:0001840) | 1.53051803 |
| 113 | Nonprogressive disorder (HP:0003680) | 1.48909713 |
| 114 | Increased muscle lipid content (HP:0009058) | 1.48224298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.12879885 |
| 2 | TTN | 5.18469251 |
| 3 | PHKG2 | 3.70315475 |
| 4 | PHKG1 | 3.70315475 |
| 5 | MYLK | 3.64372080 |
| 6 | MUSK | 3.33307581 |
| 7 | DMPK | 3.25359394 |
| 8 | PKN2 | 3.11868860 |
| 9 | LMTK2 | 2.73007937 |
| 10 | STK24 | 2.71196294 |
| 11 | PDK3 | 2.61828402 |
| 12 | PDK4 | 2.61828402 |
| 13 | TRIB3 | 2.59755647 |
| 14 | PIK3CA | 2.44501927 |
| 15 | NEK1 | 2.06583497 |
| 16 | ZAK | 1.98282180 |
| 17 | TIE1 | 1.89289458 |
| 18 | PIK3CG | 1.61950836 |
| 19 | MARK1 | 1.59776599 |
| 20 | ILK | 1.56695752 |
| 21 | BCKDK | 1.51949705 |
| 22 | PDK2 | 1.49173950 |
| 23 | PINK1 | 1.45357845 |
| 24 | CDC42BPA | 1.25955188 |
| 25 | STK38L | 1.21675602 |
| 26 | MAPK12 | 1.19916044 |
| 27 | MAP3K7 | 1.19555541 |
| 28 | ROCK1 | 1.19124240 |
| 29 | PAK3 | 1.10324465 |
| 30 | TRPM7 | 1.09754540 |
| 31 | PRKD1 | 1.09061857 |
| 32 | CAMK2D | 1.07525906 |
| 33 | MAP3K5 | 1.05299522 |
| 34 | INSRR | 1.02596157 |
| 35 | MAP2K3 | 0.96960222 |
| 36 | MAPKAPK3 | 0.95965890 |
| 37 | DAPK3 | 0.93684704 |
| 38 | NME1 | 0.90920112 |
| 39 | FLT3 | 0.83170786 |
| 40 | PRKAA2 | 0.81725123 |
| 41 | PRKAA1 | 0.81514103 |
| 42 | CCNB1 | 0.81045350 |
| 43 | GRK7 | 0.79589455 |
| 44 | RIPK1 | 0.77188356 |
| 45 | STK4 | 0.75575198 |
| 46 | WNK4 | 0.73926998 |
| 47 | PTK2B | 0.73778834 |
| 48 | PKN1 | 0.71450280 |
| 49 | MAP3K3 | 0.66508861 |
| 50 | ROCK2 | 0.64537205 |
| 51 | AKT2 | 0.63607732 |
| 52 | EEF2K | 0.61066198 |
| 53 | MAP3K10 | 0.60786524 |
| 54 | MOS | 0.59799630 |
| 55 | PDGFRA | 0.56018737 |
| 56 | WNK1 | 0.54993872 |
| 57 | MAPK4 | 0.54743219 |
| 58 | CAMK2A | 0.53215835 |
| 59 | DYRK1B | 0.53203652 |
| 60 | TGFBR2 | 0.49680108 |
| 61 | CAMK4 | 0.48518452 |
| 62 | PRKACB | 0.48510962 |
| 63 | CAMK2B | 0.48433397 |
| 64 | EPHB2 | 0.47872857 |
| 65 | STK38 | 0.47009065 |
| 66 | CAMK1 | 0.46791481 |
| 67 | SIK1 | 0.45325208 |
| 68 | RPS6KL1 | 0.44834342 |
| 69 | RPS6KC1 | 0.44834342 |
| 70 | LIMK1 | 0.44577133 |
| 71 | FRK | 0.42774039 |
| 72 | ERBB3 | 0.42528163 |
| 73 | EPHB1 | 0.42037872 |
| 74 | KDR | 0.40804791 |
| 75 | LATS1 | 0.40570160 |
| 76 | PTK6 | 0.38335017 |
| 77 | PRKACA | 0.36312474 |
| 78 | RPS6KA6 | 0.35138674 |
| 79 | MAPK13 | 0.34835371 |
| 80 | CAMK2G | 0.34270643 |
| 81 | LATS2 | 0.33120493 |
| 82 | NEK9 | 0.32564656 |
| 83 | MAPK7 | 0.32471109 |
| 84 | TNIK | 0.31744711 |
| 85 | PRKCE | 0.31511997 |
| 86 | EPHA3 | 0.31297416 |
| 87 | PRKG1 | 0.31117115 |
| 88 | SGK2 | 0.30575583 |
| 89 | ICK | 0.30371450 |
| 90 | MTOR | 0.27663569 |
| 91 | BMPR1B | 0.26583720 |
| 92 | STK11 | 0.26579170 |
| 93 | SGK3 | 0.26284236 |
| 94 | MAP2K1 | 0.25470047 |
| 95 | PRKACG | 0.25446143 |
| 96 | DAPK2 | 0.21536724 |
| 97 | FER | 0.21427002 |
| 98 | MARK3 | 0.20281080 |
| 99 | ADRBK1 | 0.20131597 |
| 100 | MAPK11 | 0.20093320 |
| 101 | KSR2 | 0.19566536 |
| 102 | STK39 | 0.19480913 |
| 103 | RPS6KB2 | 0.19161548 |
| 104 | MAP4K2 | 0.17618102 |
| 105 | RPS6KA3 | 0.17130962 |
| 106 | PDPK1 | 0.16825645 |
| 107 | PRKG2 | 0.16693239 |
| 108 | MAPK10 | 0.16485965 |
| 109 | ADRBK2 | 0.15881108 |
| 110 | RPS6KA1 | 0.14530573 |
| 111 | MAPKAPK2 | 0.14487879 |
| 112 | FGFR1 | 0.14339218 |
| 113 | NLK | 0.13853952 |
| 114 | SGK223 | 0.13566021 |
| 115 | SGK494 | 0.13566021 |
| 116 | PDK1 | 0.12846973 |
| 117 | MAPKAPK5 | 0.12336879 |
| 118 | PAK2 | 0.12065049 |
| 119 | RPS6KA2 | 0.11970821 |
| 120 | SGK1 | 0.11728897 |
| 121 | PRKCQ | 0.09378866 |
| 122 | MAP2K6 | 0.09056705 |
| 123 | PRKCH | 0.08812799 |
| 124 | PRKD3 | 0.08795459 |
| 125 | STK3 | 0.08061514 |
| 126 | MAP2K4 | 0.07956894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.44438305 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.11414146 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.89961138 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.77656820 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.85643259 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.34423408 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.94618764 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.74234817 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54411169 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44693748 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.25891219 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.20182100 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.16833108 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14471845 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.11486246 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94698437 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.81286565 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60983832 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50171642 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37057018 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34614451 |
| 22 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.32010364 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.25930883 |
| 24 | Tight junction_Homo sapiens_hsa04530 | 1.19682561 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18891860 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.16012848 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.13984849 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09240697 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07079071 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00721240 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98518430 |
| 32 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94164078 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93512517 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91866408 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90344937 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88882782 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85321439 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80517092 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80278401 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78172018 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 0.78055029 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75519181 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 0.73541642 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.72395003 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72086567 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71421479 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68017782 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65650740 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64343007 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63185969 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61830569 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59600237 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57498276 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55914953 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.55762528 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55728803 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53307272 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50916320 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.50351461 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49552833 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49174594 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48993970 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48377800 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48326083 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.46390670 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46189016 |
| 67 | Insulin secretion_Homo sapiens_hsa04911 | 0.45550059 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45365177 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44789517 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43811851 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42267804 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41268618 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41009413 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.39705670 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39094211 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38708947 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37726147 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34489528 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34135635 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32818335 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.31739099 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31070185 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30966857 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30328865 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29336289 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28447370 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28440860 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26401058 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25739487 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24344812 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.23692391 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23565423 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23151820 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22885870 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22638223 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22309071 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22089349 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20024578 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19115591 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17510417 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16484632 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16281422 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14178591 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.13233385 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12552314 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11786677 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.11618467 |
| 108 | Gap junction_Homo sapiens_hsa04540 | 0.11475310 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.11044543 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09934998 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.08473445 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.08367388 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07391692 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.07006854 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06046324 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.05321361 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04707008 |
| 118 | Taste transduction_Homo sapiens_hsa04742 | 0.04127076 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.04030255 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03723361 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.03448764 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.03265663 |
| 123 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.02972363 |

